Insider Transactions in Q3 2024 at Bicara Therapeutics Inc. (BCAX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,000
+3.75%
|
$1,260,000
$18.0 P/Share
|
|
Sep 17
2024
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,725,174
+50.0%
|
-
|
|
Sep 16
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,833,000
+16.76%
|
$32,994,000
$18.0 P/Share
|
|
Sep 16
2024
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
5,122,993
+50.0%
|
-
|
|
Sep 16
2024
|
Tpg Gp A, LLC |
BUY
Conversion of derivative security
|
Indirect |
1,960,425
+50.0%
|
-
|
|
Sep 16
2024
|
Fil LTD |
BUY
Conversion of derivative security
|
Indirect |
1,013,853
+41.23%
|
-
|
|
Sep 16
2024
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
1,115,333
+41.88%
|
-
|
|
Sep 16
2024
|
Kiran Mazumdar Shaw |
BUY
Conversion of derivative security
|
Indirect |
6,165,428
+49.84%
|
-
|
|
Sep 16
2024
|
Biocon LTD |
BUY
Conversion of derivative security
|
Indirect |
5,408,140
+49.67%
|
-
|